This Group Learning activity has been certified by the College of Family Physicians of Canada for up to 2.75 Mainpro+® certified credits.

Members of the American Academy of Family Physicians are eligible to receive up to 2.75 Prescribed credit hours for attendance at this meeting/event due to a reciprocal agreement with the College of Family Physicians of Canada

Overall Learning Objectives:

1. Recognize and diagnose fatty liver disease, including MASLD and MASH, in at-risk patient populations through appropriate screening and assessment tools.

2. Select and interpret appropriate diagnostic investigations to evaluate suspected cases of fatty liver disease.

3. Implement evidence-based treatment strategies for patients with hepatic steatosis, tailoring interventions to individual risk profiles and disease severity.

4. Identify and refer patients with advanced or high-risk fatty liver disease to specialized care for further management

MODERATOR: RICK WARD

Thursday, December 4, 2025
6:00 PM - 6:05 PM
 
6:05 PM - 6:30 PM
  • Define MASLD and MASH using current, practical terminology.
  • Identify key screening criteria and risk factors for fatty liver disease in primary care.
  • Summarize updated guidelines and nomenclature relevant to MASLD and MASH.
6:30 PM - 7:00 PM
  • Select appropriate laboratory and non-invasive tests for the assessment of fatty liver disease.
  • What labs to order
  • Demonstrate how to integrate liver health assessments into routine patient visits.
  • Interpret results from NITs (FIB-4, Transient Elastography, ultrasound, ELF, and non-invasive scores) and determine when to use each tool.
  • Apply workflow strategies to optimize efficiency and improve patient care in primary care settings.
7:00 PM - 7:25 PM
  • Describe common barriers patients face in accessing care for MASLD/MASH (e.g., stigma, confusion, fear).
  • Discuss patient experiences and factors that contributed to successful management.
  • Assess the impact of primary care interventions on patient outcomes.
7:25 PM - 7:55 PM
  • Addressing real world nutritional advice – Practical strategies for Primary Care
  • Addressing real world exercise advice - Practical strategies for Primary Care
  • Recommend practical nutritional and lifestyle strategies for patients with fatty liver disease.
  • Address patient challenges and stigma related to lifestyle modification.
  • Demonstrate brief, effective lifestyle interventions suitable for busy clinical settings
7:55 PM - 8:25 PM
  • Review the role of GLP-1s, statins, insulin sensitizers, and emerging therapies in MASLD/MASH management.
  • Evaluate medication choices considering comorbidities such as T2D, obesity, CKLM and bariatric surgery
  • Summarize current and upcoming guidelines for pharmacologic management.
8:25 PM - 8:55 PM
  • Analyze real-world cases to identify appropriate diagnostic and management strategies for diabetes and obesity
  • Evaluate patient with advanced fibrosis on Transient Elastography but no symptoms
  • Evaluate Young patient with obesity and normal liver enzymes
  • Differentiate between patients who require specialist referral and those manageable in primary care.
  • Formulate individualized care plans based on case scenarios.
8:55 PM - 9:00 PM
 
Time Zone: (UTC-05:00) Eastern Time (US & Canada) [Change Time Zone]

*Content subject to changes